RNS Number:9463T
UraMin Inc
29 March 2007





29 March 2007

                                  UraMin Inc.

                          ("UraMin" or the "Company")


The Company announces that on the recommendation of the Remuneration Committee
it has granted options over a further 6,410,000 ordinary shares of no par value
under its share option scheme to directors, employees and consultants at an
exercise price of #2.47 per share. The directors to whom options have been
granted are:


- An option over 1,400,000 shares to Ian Stalker, Chief Executive Officer (total
5,400,000 shares under option following this grant)


- An option over 1,400,000 shares to Stephen Dattels, Deputy Chairman (total
4,000,000 shares under option following this grant)


- An option over 400,000 shares to Neil Herbert, Finance Director (total
2,700,000 shares under option following this grant)


- An option over 100,000 shares to James Pitman, Vice President Corporate
Affairs (total 1,900,000 shares under option following this grant)



The remaining 3,110,000 options were granted to management, employees and
consultants of the Company.


The options will vest over in three equal annual instalments commencing on the
date of grant and will expire in 2017.



For further information:


UraMin

Ian Stalker, Chief Executive Officer

Neil Herbert, Finance Director

Tel: +27 (0)11 783 5056


Canaccord Adams Limited

Robin Birchall/ Tyler Broda

Tel: +44 (0) 20 7050 6500


Heenan Blaikie LLP

Steve Vaughan

Toronto

+1 416 643 6924


FD

Ben Brewerton

Edward Westropp

-+44 20 7269 7230


Background Information:

UraMin (www.uramin.com) was established in 2005 to acquire and develop mineral 
properties, predominantly uranium. Following the private placement the Company 
currently working capital of approximately US$300 million and a market 
capitalization of approximately US$1.3 billion on an undiluted basis. UraMin 
(www.uramin.com) is traded on the Alternative Investment Market of the London 
Stock Exchange plc and the Toronto Stock Exchange under the symbol UMN.

UraMin is currently focusing on the development of its advanced stage 
exploration projects at Trekkopje in Namibia, Bakouma in the Central African 
Republic and Ryst Kuil in South Africa. Through a South African joint venture, 
UraMin also enjoys additional prospecting license applications for important 
uranium deposits in the Karoo, South Africa. No assurance can be given that 
remaining applications for prospecting licences will be successful.



Forward-Looking Statements:


This press release contains statements that are "forward-looking". Generally,
the words "expect," "intend," "estimate," "will" and similar expressions
identify forward-looking statements. By their very nature, forward-looking
statements are subject to known and unknown risks and uncertainties that may
cause our actual results, performance or achievements, or that of our industry,
to differ materially from those expressed or implied in any of our
forward-looking statements. Statements in this press release regarding the
Company's business or proposed business, which are not historical facts, are
"forward looking" statements that involve risks and uncertainties, such as
estimates and statements that describe the Company's future plans, objectives or
goals, including words to the effect that the Company or management expects a
stated condition or result to occur. Since forward-looking statements address
future events and conditions, by their very nature, they involve inherent risks
and uncertainties. Actual results in each case could differ materially from
those currently anticipated in such statements.


Investors are cautioned not to place undue reliance on forward-looking
statements, which speak only as of the date they are made.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCBCGDXUDDGGRI

Grafico Azioni Uramin (LSE:UMN)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Uramin
Grafico Azioni Uramin (LSE:UMN)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Uramin